PANCREATIC BETA-CELL SPECIFIC DELETION OF ABCA1 AND ABCG1 PERTURBS GLUCOSE METABOLISM AND INCREASES ADIPOSITY IN MICE DUE TO SUBOPTIMAL PLASMA INSULIN LEVELS

被引：0
|
作者：
Cochran, B. J. [1 ]
Hou, L. [1 ]
Manavalan, A. P. Chirackal [1 ]
Sultana, A. [1 ]
Moore, B. M. [2 ]
Patel, M. [1 ]
Tall, A. [3 ]
Barter, P. J. [1 ]
Rye, K. A. [1 ]
机构：
[1] UNSW Australia, Ctr Vasc Res, Sydney, NSW, Australia
[2] Royal Prince Alfred Hosp, Dept Med, Sydney, NSW, Australia
[3] Columbia Univ, Dept Med, New York, NY USA
来源：
ATHEROSCLEROSIS | 2015年 / 241卷 / 01期
关键词：
D O I：
10.1016/j.atherosclerosis.2015.04.028
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EAS-0748
引用
收藏
页码：E3 / E3
页数：1
相关论文
共 11 条
  • [1] Pancreatic β-Cell-Specific Deletion of ABCA1 and ABCG1 Perturbs Glucose Metabolism and Increases Adiposity in Mice
    Cochran, Blake J.
    Hou, Liming
    Moore, Benjamin M.
    Sultana, Afroza
    Tall, Alan R.
    Barter, Philip J.
    Rye, Kerry-Anne
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34
  • [2] SKELETAL MUSCLE SPECIFIC DELETION OF ABCA1 AND ABCG1 IMPACTS BODY COMPOSITION AND METABOLISM AND IS AGE DEPENDENT
    Tan, W. T.
    Kopecky, C.
    Manandhar, B.
    Rye, K. A.
    Cochran, B.
    ATHEROSCLEROSIS, 2019, 287 : E43 - E43
  • [3] LIPIDS AND LIPOPROTEINS. BETA CELL-SPECIFIC DELETION OF ABCA1 AND ABCG1 REGULATES THE INCREASE OF SMALL NUCLEOLAR RNAS IN ADIPOCYTES
    Tabet, F.
    Hou, L.
    Cochran, B.
    Torres, L. F. Cuesta
    Barter, P. J.
    Rye, K. A.
    ATHEROSCLEROSIS, 2016, 252 : E199 - E199
  • [4] Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels
    Out, Ruud
    Hoekstra, Menno
    Habets, Kim
    Meurs, Illiana
    de Waard, Vivian
    Hildebrand, Reeni B.
    Wang, Yanan
    Chimini, Giovanna
    Kuiper, Johan
    Van Berkel, Theo J. C.
    Van Eck, Miranda
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (02) : 258 - 264
  • [5] The Anti-atherosclerosis ABCA1 Agonist CS6253 Confer Glucose Control by Improved Pancreas Beta-cell Insulin Secretion and Enhanced Peripheral Insulin Utility
    Bielicki, John K.
    Hafiane, Anouar
    Genest, Jacques
    Johansson, Jan O.
    Bittner, Stefanie
    Hu, Jie
    Tabassum, Juveri
    Azhar, Salman
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36
  • [6] Wnt4 antagonises Wnt3a mediated increases in growth and glucose stimulated insulin secretion in the pancreatic beta-cell line, INS-1
    Bowen, A.
    Kos, K.
    Whatmore, J.
    Richardson, S.
    Welters, H. J.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 479 (04) : 793 - 799
  • [7] Elevated 1-hour plasma glucose levels are associated with dysglycemia, impaired beta-cell function, and insulin sensitivity: a pilot study from a real world health care setting
    Ram Jagannathan
    Mary Ann Sevick
    Huilin Li
    Dorothy Fink
    Rachel Dankner
    Angela Chetrit
    Jesse Roth
    Michael Bergman
    Endocrine, 2016, 52 : 172 - 175
  • [8] Elevated 1-hour plasma glucose levels are associated with dysglycemia, impaired beta-cell function, and insulin sensitivity: a pilot study from a real world health care setting
    Jagannathan, Ram
    Sevick, Mary Ann
    Li, Huilin
    Fink, Dorothy
    Dankner, Rachel
    Chetrit, Angela
    Roth, Jesse
    Bergman, Michael
    ENDOCRINE, 2016, 52 (01) : 172 - 175
  • [9] [I10W]tigerinin-1R enhances both insulin sensitivity and pancreatic beta cell function and decreases adiposity and plasma triglycerides in high-fat mice
    Dinesh K. Srinivasan
    Opeolu O. Ojo
    Bosede O. Owolabi
    J. Michael Conlon
    Peter R. Flatt
    Yasser H. A. Abdel-Wahab
    Acta Diabetologica, 2016, 53 : 303 - 315
  • [10] [I10W]tigerinin-1R enhances both insulin sensitivity and pancreatic beta cell function and decreases adiposity and plasma triglycerides in high-fat mice
    Srinivasan, Dinesh K.
    Ojo, Opeolu O.
    Owolabi, Bosede O.
    Conlon, J. Michael
    Flatt, Peter R.
    Abdel-Wahab, Yasser H. A.
    ACTA DIABETOLOGICA, 2016, 53 (02) : 303 - 315
12